Bringing a prophylactic Ebola vaccine to licensure

Project Information

EBOVAC3

Grant agreement ID: 800176

DOI

10.3030/800176

Project closed

EC signature date 15 June 2018

Start date 1 June 2018

End date 30 September 2024

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 50 979 889,71

EU contribution

€ 29 402 655,71

Coordinated by

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (2)

Pilot on integrated solution linking vaccine label to biometric profile
Communication tools and brand identity: key messaging documents, project website, flyer, core presentations

Publications

Other (4)

Safety and immunogenicity of the heterologous two-dose Ad26.ZEBOV, MVA-BN-Filo vaccine regimen in healthcare providers and frontliners of the Democratic Republic of the Congo.

Author(s): Y Larivière, I Garcia-Fogeda, T Zola Matuvanga et al.
Published in: 2023
Publisher: UAntwerp / UNIKIN
DOI: 10.1093/infdis/jiad350

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach

Author(s): Clairon, Quentin; Pasin, Chloé; Balelli, Irene; Thiébaut, Rodolphe; Prague, Mélanie
Published in: HAL Open Science, Issue 1, 2021
Publisher: HAL Open Science
DOI: 10.13140/rg.2.2.18016.81920

Researchers’ responsibility in low-resource settings: experiences of an ancillary care policy and practices in a vaccine trial in the Democratic Republic of the Congo

Author(s): Gwen Lemey, T Zola Matuvanga, Ynke Larivière, Solange Milolo, Engbu Danoff, Lazarre Bakonga, Emmanuel Esanga, Peter Vermeiren, Vivi Maketa, Junior Matangila, Patrick Mitashi, Pierre Van Damme, Jean-Pierre Van geertruyden , Raffaella Ravinetto, Hypolite Muhindo-Mavoko
Published in: Research Ethics, 2023
Publisher: UAntwerp
DOI: 10.1177/17470161231194139

Rapport final Etude de la résurgence de la Maladie à Virus Ébola dans la région de Nzérékoré par l’équipe du CERFIG-RKI-IRD-UNICEF

Author(s): Saez, Almudena Mari, Frederic Le Marcis et al.
Published in: 2021
Publisher: Institute of Research for Development
DOI: 10.13140/rg.2.2.14143.84641

Peer reviewed articles (6)

Setting up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned

Author(s): Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Jessie De Bie , Solange Milolo, Rachel Meta, Emmanuel Esanga, Paul Peter Vermeiren , Séverine Thys, Jean-Pierre Van geertruyden , Pierre Van Damme, Vivi Maketa, Junior Matangila , Patrick Mitashi, Hypolite Muhindo-Mavoko
Published in: Vaccine, 2022, ISSN 0264-410X
Publisher: Elsevier BV
DOI: 10.1016/j.vaccine.2022.04.094

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Author(s): Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden J, Van Damme P, Muhindo Mavoko H.
Published in: Journal of Medical Internet Research, 2021, ISSN 1438-8871
Publisher: Journal of medical Internet Research
DOI: 10.2196/28573

Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo

Author(s): Lemey, Gwen, Ynke Larivière, Trésor Zola, Hypolite Muhindo, Vivi Maketa, Patrick Mitashi, Junior Matangila, Peter Vermeiren, Jessie De Bie, Jean-Pierre Van geertruyden, Pierre Van Damme
Published in: BMJ Global Health, 2021, ISSN 2059-7908
Publisher: BMJ Global Health
DOI: 10.1136/bmjgh-2021-005726

Resurgence of Ebola Virus in 2021 in Guinea Suggests a New Paradigm for Outbreaks

Author(s): Keita, Alpha Kabinet, Fara R. Koundouno, Martin Faye, Ariane Düx, Julia Hinzmann, Haby Diallo, Ahidjo Ayouba, Le Marcis, Frédéric et al. 2021.
Published in: Nature, 2021, ISSN 1476-4687
Publisher: Nature
DOI: 10.1038/s41586-021-03901-9

Potential Test-Negative Design Study Bias in Outbreak Settings: Application to Ebola vaccination in Democratic Republic of Congo

Author(s): Carl B Pearson, W John Edmunds, Thomas J Hladish, Rosalind M Eggo
Published in: International Journal of Epidemiology, 2022, ISSN 0300-5771
Publisher: Oxford University Press
DOI: 10.1093/ije/dyab172

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol

Author(s): Ynke Larivière, Trésor Zola, Elke Stoppie, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Hypolite Muhindo, Jean-Pierre Van geertruyden, Pierre Van Damme
Published in: BMJ Open, 2021, ISSN 2044-6055
Publisher: BMJ Publishing Group
DOI: 10.1136/bmjopen-2020-046835